| 000 | 01820 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514220829.0 | ||
| 264 | 0 | _c20050404 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-03-3986 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVosseler, Silvia | |
| 245 | 0 | 0 |
_aAngiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. _h[electronic resource] |
| 260 |
_bCancer research _cFeb 2005 |
||
| 300 |
_a1294-305 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xblood supply |
| 650 | 0 | 4 |
_aCell Growth Processes _xphysiology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCollagenases _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMatrix Metalloproteinase 13 |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xbiosynthesis |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xenzymology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aStromal Cells _xenzymology |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 700 | 1 | _aMirancea, Nicolae | |
| 700 | 1 | _aBohlen, Peter | |
| 700 | 1 | _aMueller, Margareta M | |
| 700 | 1 | _aFusenig, Norbert E | |
| 773 | 0 |
_tCancer research _gvol. 65 _gno. 4 _gp. 1294-305 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-03-3986 _zAvailable from publisher's website |
| 999 |
_c15409332 _d15409332 |
||